Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT05471752
Recruiting Observational

Isolation, Characterization and Evaluation of the Potential of TissuE-resideNt cElls From Waste Musculoskeletal and Associated Connective Tissues

NCT05471752 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2022-05-11
Last updated
2022-07-25

Condition(s) studied

Musculoskeletal Diseases

Study summary

The general purpose of this study is characterization of tissue-resident cells derived from different musculoskeletal and/or associated connective tissues (such as cartilage, synovial membrane, synovial fluid, bone, adipose tissue and tendons), in order to identify new strategies for the treatment of degenerative and inflammatory musculoskeletal disorders. Cells isolated from different tissue sources will be compared with each other by phenotypic and functional characterization, following culture and treatment with inflammatory elements, drugs and orthobiologics. Moreover, with the aim to assess predictive markers of therapeutic success, a correlation study of the content and properties of the cells isolated from different types of tissue with the clinical profile of the enrolled patients will be conducted.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * males and females * 18 years old * patients undergoing elective surgery at IRCCS Istituto Ortopedico Galeazzi among which joint surgery (including hip or knee replacement), or anterior cruciate ligament (ACL) reconstruction or rotator cuff repair Exclusion Criteria: * age \< 18 years old * patients unable to sign the Informed Consent * positivity to virological test (HIV, HCV, HBV, TPHA)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
IRCCS Istituto Ortopedico Galeazzi Milan Italy Recruiting

More I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05471752 on ClinicalTrials.gov ↗ ← All trials in Italy